on ADOCIA (EPA:ADOC)
ADOCIA Secures €6 Million Shareholder Loan from Vester Finance
ADOCIA, a clinical-stage biopharmaceutical company, announced a shareholder loan agreement with Vester Finance to extend its cash runway to Q2 2027. The agreement allows up to €6 million, with €1.5 million disbursed upon signing. The loan may be repaid in shares or cash. This deal strengthens ADOCIA's financial position as it focuses on its BioChaperone® and AdoXLong™ platforms.
The transaction reflects Vester Finance's confidence in ADOCIA, having increased its stake to 4.2% of the company. ADOCIA retains the option to terminate the agreement at no cost beyond the initial advance. Risks related to share volatility and liquidity remain, but governance is unaffected.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ADOCIA news